Semtech Demonstrates LoRa® Technology Solution for IoT at ST Developers Conference
Sep 28, 2016 12:01 pm UTC| Business
SANTA CLARA, Calif., Sept. 28, 2016 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, will showcase its LoRa® Wireless RF Technology for the Internet of Things (IoT) at...
FRONTEO Obtains U.S. Patents for AI-based Technology Enabling High-level Text Analysis
Sep 28, 2016 12:01 pm UTC| Business
TOKYO, Sept. 28, 2016 -- FRONTEO, Inc. (“FRONTEO” or “the Company”) (Nasdaq:FTEO) (TSE:2158), which provides big-data analytics services using its proprietary Artificial Intelligence (“AI”) engine, today announced that...
FRONTEO Obtains U.S. Patents for AI-based Technology Enabling High-level Text Analysis
Sep 28, 2016 12:01 pm UTC| Business
TOKYO, Sept. 28, 2016 -- FRONTEO, Inc. (“FRONTEO” or “the Company”) (Nasdaq:FTEO) (TSE:2158), which provides big-data analytics services using its proprietary Artificial Intelligence (“AI”) engine, today announced that...
Sep 28, 2016 12:01 pm UTC| Business
Strategic Transaction Validates TRACON’s Unique Clinical Development Capabilities $5 Million Equity Investment Strengthens TRACON’s Balance Sheet SAN DIEGO, Sept. 28, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a...
Sep 28, 2016 12:01 pm UTC| Business
NEW YORK, Sept. 28, 2016 -- MASS Communications announced today the company’s selection to Crain’s 2016 100 Best Places to Work in New York City for the second year in a row. The prestigious award from Crain’s New...
Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development
Sep 28, 2016 12:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 28, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced the application of its GLAAS discovery platform in...
Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development
Sep 28, 2016 12:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 28, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced the application of its GLAAS discovery platform in...